AR069311A1 - Proceso para preparar (r)-5-(2-aminoetil)-1-(6,8-difluorocroman-3-il)-1,3-dihidroimidazol-2-tiona y compuestos intermediarios de sintesis - Google Patents

Proceso para preparar (r)-5-(2-aminoetil)-1-(6,8-difluorocroman-3-il)-1,3-dihidroimidazol-2-tiona y compuestos intermediarios de sintesis

Info

Publication number
AR069311A1
AR069311A1 ARP080104958A ARP080104958A AR069311A1 AR 069311 A1 AR069311 A1 AR 069311A1 AR P080104958 A ARP080104958 A AR P080104958A AR P080104958 A ARP080104958 A AR P080104958A AR 069311 A1 AR069311 A1 AR 069311A1
Authority
AR
Argentina
Prior art keywords
compound
formula
halogen
term
alkyl
Prior art date
Application number
ARP080104958A
Other languages
English (en)
Spanish (es)
Original Assignee
Bial Portela & Ca Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela & Ca Sa filed Critical Bial Portela & Ca Sa
Publication of AR069311A1 publication Critical patent/AR069311A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP080104958A 2007-11-13 2008-11-13 Proceso para preparar (r)-5-(2-aminoetil)-1-(6,8-difluorocroman-3-il)-1,3-dihidroimidazol-2-tiona y compuestos intermediarios de sintesis AR069311A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98746707P 2007-11-13 2007-11-13
US8592708P 2008-08-04 2008-08-04

Publications (1)

Publication Number Publication Date
AR069311A1 true AR069311A1 (es) 2010-01-13

Family

ID=40550012

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080104958A AR069311A1 (es) 2007-11-13 2008-11-13 Proceso para preparar (r)-5-(2-aminoetil)-1-(6,8-difluorocroman-3-il)-1,3-dihidroimidazol-2-tiona y compuestos intermediarios de sintesis

Country Status (13)

Country Link
US (1) US20100298580A1 (OSRAM)
EP (1) EP2217585A2 (OSRAM)
JP (1) JP2011503175A (OSRAM)
KR (1) KR20100102606A (OSRAM)
CN (1) CN101952271A (OSRAM)
AR (1) AR069311A1 (OSRAM)
AU (1) AU2008321625A1 (OSRAM)
BR (1) BRPI0818105A2 (OSRAM)
CA (1) CA2705512A1 (OSRAM)
MX (1) MX2010005193A (OSRAM)
RU (1) RU2010123778A (OSRAM)
TW (1) TW200927740A (OSRAM)
WO (1) WO2009064210A2 (OSRAM)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201316410D0 (en) 2013-09-13 2013-10-30 Bial Portela & Ca Sa Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein
US11875700B2 (en) 2014-05-20 2024-01-16 Jessica Robinson Systems and methods for providing communication services
CN110590728B (zh) * 2019-10-15 2022-03-22 青岛科技大学 一种多取代4-苯基色满类化合物的合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0232279B2 (ja) * 1982-08-12 1990-07-19 Kowa Co Jihidorobenzopiranjioorunoseiho
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
BR9507517A (pt) * 1994-04-26 1997-09-16 Syntex Inc Derivados de benzocicloalquilazotetiona
US6867224B2 (en) * 2002-03-07 2005-03-15 Warner-Lambert Company Compounds that modulate PPAR activity and methods of preparation
JP2004075614A (ja) * 2002-08-20 2004-03-11 Sankyo Co Ltd クロメン誘導体を含有する医薬
US7125904B2 (en) * 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
US20050032873A1 (en) * 2003-07-30 2005-02-10 Wyeth 3-Amino chroman and 2-amino tetralin derivatives
US7456214B2 (en) * 2004-05-03 2008-11-25 Baylor University Chromene-containing compounds with anti-tubulin and vascular targeting activity
US20050245489A1 (en) * 2004-05-03 2005-11-03 Pinney Kevin G Chromene-containing compounds with anti-tubulin and vascular targeting activity
BRPI0512623A (pt) * 2004-06-25 2008-03-25 Janssen Phamaceutica N V sal quaternário antagonista de ccr2
JP5193602B2 (ja) * 2004-10-14 2013-05-08 アボット ゲーエムベーハー ウント カンパニー カーゲー ドーパミンd3受容体の調節に応答する障害の治療に好適なアリールスルホニルメチルまたはアリールスルホンアミド置換芳香族化合物
KR20080074220A (ko) * 2005-12-08 2008-08-12 밀레니엄 파머슈티컬스 인코퍼레이티드 키나아제 억제 활성을 갖는 비시클릭 화합물
RU2009126571A (ru) * 2006-12-12 2011-01-20 Биал-Портела Энд Ка, С.А. (Pt) Каталитический способ асимметричной гидрогенизации

Also Published As

Publication number Publication date
JP2011503175A (ja) 2011-01-27
MX2010005193A (es) 2010-06-02
WO2009064210A2 (en) 2009-05-22
CA2705512A1 (en) 2009-05-22
EP2217585A2 (en) 2010-08-18
BRPI0818105A2 (pt) 2019-09-24
TW200927740A (en) 2009-07-01
CN101952271A (zh) 2011-01-19
KR20100102606A (ko) 2010-09-24
RU2010123778A (ru) 2011-12-20
AU2008321625A1 (en) 2009-05-22
US20100298580A1 (en) 2010-11-25
WO2009064210A3 (en) 2009-12-30

Similar Documents

Publication Publication Date Title
PE20121048A1 (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
ES2188016T3 (es) Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas.
ES2452299T3 (es) Compuestos heterocíclicos fungicidas
PE20130375A1 (es) Compuestos de triazolopiridinas y triazolopirazinas inhibidores de c-met y composiciones de los mismos
CO6300864A2 (es) Derivados polisustituidos de 6-heteroaril-imidazo[1,2-a]piridinas su preparacion y su aplicacion en terapeutica
AR061369A1 (es) Derivados de pirimidina y composiciones farmaceuticas que los comprenden
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
ES2530891T3 (es) Sistema catalizador de oligomerización y procedimiento para oligomerizar olefinas
AR060506A1 (es) Compuestos organicos
ES2422204T3 (es) Novedosos derivados de imidazolidin-2-ona como moduladores selectivos de receptor de andrógenos (SARMS)
UY31014A1 (es) Derivados de ftalazinona
AR060595A1 (es) Un proceso para preparar derivados enantiomericos de dibenz[b,f]-azepina
NI201000049A (es) Método para producir 2'-desoxi-5-azacitidina (decitabina)
CY1114927T1 (el) Νεα 2-υποκατεστημενα παραγωγα μεθυλο πεναμης
BR112012033690A2 (pt) sais de cálcio de compostos como agentes anti-inflamatórios, imunomodulares e antitroliferativos
CO6362013A2 (es) Derivados de rifamicina
BR112013008675A2 (pt) métodos e composições para o tratamento de diabetes e dislipidemia
AR069311A1 (es) Proceso para preparar (r)-5-(2-aminoetil)-1-(6,8-difluorocroman-3-il)-1,3-dihidroimidazol-2-tiona y compuestos intermediarios de sintesis
AR071217A1 (es) Derivados bencimidazol
CR11578A (es) Derivados de oxadiazol activos e 1-fosfato de esfingosina
NO20092259L (no) Prosess
CY1117026T1 (el) Ετεροκυκλικες ενωσεις για αντιμετωπιση ή προληψη διαταραχων που προκαλουνται απο μειωμενη νευροδιαβιβαση σεροτονινης, νορεπινεφρινης ή ντοπαμινης
CO6551700A2 (es) Fungicidas de azolil benceno heterobiciclico- sustituidos
CO5700763A2 (es) Derivados de 1-bencil-5-piperazin-1-il-3,4-dihidro-1h-quinazolin-2-ona y el respexctivo 1h-benzo (1,2,6)tiadiazin-2,2-dioxido y derivados de 1,4-dihidro-benzo (d) (1,3) oxazin-2-ona como moduladores del receptor 5-hidroxitriptamina (5-ht) para el tra
BRPI0804917A2 (pt) métodos para produzir uma nitrona e para estabilizar combustìvel ou óleo lubrificante, e, composto

Legal Events

Date Code Title Description
FB Suspension of granting procedure